NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Proteome Sciences plc (F: PI2)

 
PI2 Technical Analysis
4
As on 14th Jul 2025 PI2 SHARE Price closed @ 0.03 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.05 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PI2SHARE Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.00 0.00
Volume 2000 1 Year -0.01 -25.00
52 Week High 0.06 | 52 Week Low 0.02
 
F Germany Most Active Stocks
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
ENB 47.60 -0.92%
TEF 3.84 -0.52%
TEF 3.84 -0.52%
WHL 5150.00 -0.44%
WDI 0.05 -37.50%
 
F Germany Top Gainers Stocks
JYR 1000000.00 10000000000.00%
JYR 1000000.00 10000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
LAW 1000000.00 5000000000.00%
0AI 11.30 14025.00%
0AI 11.30 14025.00%
SUE1 12.60 12500.00%
4CIA 3.17 2541.67%
 
F Germany Top Losers Stocks
TINC 0.01 -99.92%
TINC 0.01 -99.92%
TINC 0.01 -99.92%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
IMU 0.10 -99.65%
LDB 1.71 -92.57%
 
 
PI2
Daily Charts
PI2
Intraday Charts
Whats New @
Bazaartrend
PI2
Free Analysis
 
PI2 Important Levels Intraday
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
RESISTANCE0.03
 
PI2 Forecast July 2025
4th UP Forecast0.07
3rd UP Forecast0.06
2nd UP Forecast0.05
1st UP Forecast0.04
1st DOWN Forecast0.02
2nd DOWN Forecast0.01
3rd DOWN Forecast0
4th DOWN Forecast-0.01
 
PI2 Weekly Forecast
4th UP Forecast0.03
3rd UP Forecast0.03
2nd UP Forecast0.03
1st UP Forecast0.03
1st DOWN Forecast0.03
2nd DOWN Forecast0.03
3rd DOWN Forecast0.03
4th DOWN Forecast0.03
 
PI2 Forecast2025
4th UP Forecast0.11
3rd UP Forecast0.08
2nd UP Forecast0.07
1st UP Forecast0.05
1st DOWN Forecast0.01
2nd DOWN Forecast-0.01
3rd DOWN Forecast-0.02
4th DOWN Forecast-0.05
 
 
PI2 Other Details
Segment EQ
Market Capital 16874316.00
Sector Healthcare
Industry Diagnostics & Research
Offical website >
 
PI2 Address
PI2
 
PI2 Latest News
 
Your Comments and Response on Proteome Sciences plc
 
PI2 Business Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, and European Union. The company develops the technology for isobaric tandem mass tag (TMT) and TMTpro; and manufactures small and protein-reactive chemical reagents. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the most important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay for multi-protein biomarker panels. It primarily serves pharmaceutical and biotechnology companies, including academic research. The company was incorporated in 1993 and is headquartered in Addlestone, the United Kingdom. Address: 5 Dashwood Lang Road, Addlestone, United Kingdom, KT15 2HJ
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service